Tag: Cardiovascular Systems

Sapphire II PRO becomes US’s first and only 1mm coronary balloon

Cardiovascular Systems has announced that the US FDA has granted 510(k) clearance for the OrbusNeich 1mm Sapphire II PRO coronary balloon. The approval means...

Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial

Cardiovascular Systems and the Cardiovascular Research Foundation (CRF) have announced that the first subject has been enrolled in the ECLIPSE clinical trial. The subject...

Atherectomy is an important tool for optimising results of PCI in...

Evan Shlofmitz (Northwell Health, Manhasset, USA) presented the results of the COAP-PCI (Clinical outcomes of atherectomy prior to percutaneous coronary intervention) study at Cardiovascular...

Martha Goldberg Aronson joins Cardiovascular Systems board of directors

Cardiovascular Systems (CSI) has announced the addition of independent board member Martha Goldberg Aronson, an experienced business executive with deep healthcare and medical industry...

Cardiovascular Systems Micro Crown sustains high freedom from major adverse events...

Cardiovascular Systems (CSI) has released one-year results from its Coronary Orbital Atherectomy System Study (COAST) in a late-breaking presentation at the 2017 Cardiovascular Research...

Study demonstrates sustained benefit of endovascular intervention in patients with lower...

Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market study in a presentation at the 29th International Symposium on Endovascular Therapy...